A case report of extranodal NK/T cell lymphoma nasal-type with direct pulmonary involvement

Hui Zhang1, Jiaming Yin2, Haibo Ge1

  • 1Pulmonary and Critical Care Medicine, Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing, Jiangsu Province, China.

Medicine
|September 24, 2025
PubMed
Abstract

Insights

Extranodal nasal-type NK/T-cell lymphoma rarely affects the lungs. Prompt lung biopsy is crucial for diagnosing this rare pulmonary manifestation, especially when initial treatments fail.

Area of Science:

  • Hematology
  • Oncology
  • Pathology

Background:

  • Extranodal nasal-type NK/T-cell lymphoma typically affects the nasal cavity.
  • Pulmonary involvement is rare and often misdiagnosed.

Purpose of the Study:

  • To report a rare case of extranodal NK/T-cell lymphoma with predominant lung infiltration.
  • To highlight the diagnostic challenges and effective treatment strategies for this condition.

Main Methods:

  • Case report of a 45-year-old male with refractory lymphoma.
  • Initial treatment with anti-infectives and a chemotherapy regimen (peASPARTASE + methotrexate + etoposide + dexamethasone) was ineffective.
  • Diagnosis confirmed via percutaneous lung biopsy.
  • Treatment adjusted to gemcitabine, oxaliplatin, and PD-1 inhibitor therapy.

Main Results:

  • The patient presented with recurrent fever and cough, initially unresponsive to treatment.
  • Chest CT showed disease progression with lung infiltration, bone marrow, and adrenal gland involvement.
  • The adjusted chemotherapy regimen led to disease control.

Conclusions:

  • Pulmonary involvement in NK/T-cell lymphoma is rare but should be considered in patients with persistent fever and pulmonary lesions unresponsive to antibiotics.
  • Early diagnosis via lung biopsy is critical.
  • Combination chemotherapy including gemcitabine, oxaliplatin, and PD-1 inhibitors can be effective for refractory disease.

Related Concept Videos